ERBB2 and neoplasm: ecDNA was first observed by Cox et al. described as double minus in 1965 [2], since then it has been detected in nearly half of the cancer types carrying oncogenes, including EGFR, ERBB2, MYC etc. in tumor cell lines, as well as clinical tumor samples [3–6].